Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat autoimmune diseases.The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a... 
Sector
Pharmaceuticals
Calendar
03/04 | 10:00amPresentation
More about the company
Financials ($)
Sales 2014 -
EBIT 2014 -29,3 M
Net income 2014 -30,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -37,4 M
Net income 2015 -38,8 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 135 M
More Financials
Latest news on ANTA PHAR
03/04 ANTHERA PHARMACEUTICALS : Stocks Coverage on the Biotech Industry - Achillion Ph..
02/19 ANTHERA PHARMACEUTICALS : Announces Completion of Interim Analysis from Phase 3 ..
02/19 ANTHERA PHARMACEUTICALS : to Present at Cowen & Co. Healthcare Conference
02/11 ANTHERA PHARMACEUTICALS : Other Events (form 8-K)
02/10 APPLE : Most active Nasdaq-traded stocks
02/10 ANTHERA PHARMACEUTICALS : Regains Compliance with Nasdaq Listing Requirements
02/10 ANTHERA PHARMACEUTICALS : Announces Completion of Interim Analysis from Phase 3 ..
01/28 ANTHERA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial ..
More news
Sector news Biopharmaceuticals
09:10p JOHNSON & JOHNSON : Local woman wins $5.7 million in lawsuit against Johnson & J..
07:50pDJBiotech Bidding War Yields Rich Price
07:34pDJForeign Takeovers See U.S. Losing Tax Revenue
Plus d'actualités du secteur Biopharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF